Standard BioTools
LAB
LAB
134 hedge funds and large institutions have $472M invested in Standard BioTools in 2020 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 27 increasing their positions, 54 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 112 → 134 (+22)
4.79% more ownership
Funds ownership: 87.97% → 92.76% (+4.8%)
50% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 54
Holders
134
Holding in Top 10
4
Calls
$9.54M
Puts
$4.3M
Top Buyers
| 1 | +$23.8M | |
| 2 | +$22.3M | |
| 3 | +$15.7M | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$7.27M |
| 5 |
EP
Eversept Partners
New York
|
+$6.2M |
Top Sellers
| 1 | -$9.92M | |
| 2 | -$9.82M | |
| 3 | -$8.6M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$7.02M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$6.45M |